WASHINGTON, April 23 -- Food and Drug Administration has issued a notice called: Voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program.
The notice was published in the Federal Register on April 23 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for a limited number of drug manufacturing establishments to participate in the second year of the voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program involving the use of a refined prototype assessment protocol to evaluate quality management maturity (QMM). The Center of Drug Evaluation and Resear...